MAP2K4 Antikörper

Produktnummer ABIN1724655

Produktdetails anti-MAP2K4 Antikörper

Target: MAP2K4 (Mitogen-Activated Protein Kinase Kinase 4 (MAP2K4))

Reaktivität: Human

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser MAP2K4 Antikörper ist unkonjugiert

Applikation: Immunohistochemistry (IHC), ELISA

Verwendungszweck: MAP2K4 Antibody

Aufreinigung: Ascitic fluid

Immunogen: Purified recombinant fragment of MAP2K4 expressed in E. Coli.

Klon: 2D10D8

Isotyp: IgM

Anwendungsinformationen

Applikationshinweise: ELISA: 1/10000

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: Ascitic fluid containing 0.03 % sodium azide.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.

Referenzen für anti-MAP2K4 Antikörper (ABIN1724655)

Kim, Vander Griend, Yang, Benson, Dubauskas, Yoshida, Chekmareva, Ichikawa, Sokoloff, Zhan, Karrison, Lin, Stadler, Ichikawa, Rubin, Rinker-Schaeffer: "Mitogen-activated protein kinase kinase 4 metastasis suppressor gene expression is inversely related to histological pattern in advancing human prostatic cancers." in: Cancer research, Vol. 61, Issue 7, pp. 2833-7, (2001) (PubMed).

Cuenda: "Mitogen-activated protein kinase kinase 4 (MKK4)." in: The international journal of biochemistry & cell biology, Vol. 32, Issue 6, pp. 581-7, (2000) (PubMed).

Details zu MAP2K4

Target: MAP2K4 (Mitogen-Activated Protein Kinase Kinase 4 (MAP2K4))

Andere Bezeichnung: MAP2K4 (MAP2K4 Produkte)

Synonyme: JNKK antikoerper, JNKK1 antikoerper, MAPKK4 antikoerper, MEK4 antikoerper, MKK4 antikoerper, PRKMK4 antikoerper, SAPKK-1 antikoerper, SAPKK1 antikoerper, SEK1 antikoerper, SERK1 antikoerper, SKK1 antikoerper, Sek1 antikoerper, Serk1 antikoerper, MKK4A-l antikoerper, map2k4 antikoerper, zgc:136500 antikoerper, jnkk antikoerper, mek4 antikoerper, mkk4 antikoerper, sek1 antikoerper, jnkk1 antikoerper, serk1 antikoerper, xmek2 antikoerper, mapkk4 antikoerper, prkmk4 antikoerper, 142758_at antikoerper, CG9738 antikoerper, CT27508 antikoerper, D-MKK4 antikoerper, DMKK4 antikoerper, Dmel\\CG9738 antikoerper, JNKK2 antikoerper, Mpk4 antikoerper, SEK1/MKK4 antikoerper, dMKK4 antikoerper, dMkk4 antikoerper, hep antikoerper, ARABIDOPSIS THALIANA MITOGEN-ACTIVATED PROTEIN KINASE KINASE 4 antikoerper, ATMEK4 antikoerper, ATMKK4 antikoerper, F19C24.26 antikoerper, F19C24_26 antikoerper, MAP KINASE KINASE 4 antikoerper, mitogen-activated protein kinase kinase 4 antikoerper, MKK4B antikoerper, zgc:194486 antikoerper, mitogen-activated protein kinase kinase 4 antikoerper, mitogen-activated protein kinase kinase 4a antikoerper, MAP kinase kinase 4 antikoerper, mitogen activated protein kinase kinase 4 antikoerper, mitogen-activated protein kinase kinase 4b antikoerper, MAP2K4 antikoerper, Map2k4 antikoerper, map2k4a antikoerper, map2k4 antikoerper, Mkk4 antikoerper, MKK4 antikoerper, map2k4b antikoerper

Hintergrund:

Description: MAP2K4(mitogen-activated protein kinase kinase 4), which is located on chromosome 17p11.2, with 399-amino acid protein (about 45 kDa), belongs to the family of protein kinases located upstream of the MAP kinases and responsible for their activation has been identified. MEK-4 (also called MEK4/MKK4) activates both p38 and JNK MAP kinases.
MKK4 is a central mediator in the stress activated protein kinase signaling pathway that responds to a number of cellular and environmental stressors. By phosphorylating MAP kinases such as JNK,MKK4 can ultimately transmit stress signals to nuclear transcription factors that mediate various processes including proliferation, apoptosis, and differentiation. Its distinct biological functions have been identified for MKK4 including a role in development, hepatogenesis, and metastasis suppression.

Aliases: MAP2K4

Gen-ID: 6416

HGNC: 6416

UniProt: P45985

Pathways: MAPK Signalweg, TLR Signalweg, Fc-epsilon Rezeptor Signalübertragung, Activation of Innate immune Response, Toll-Like Receptors Cascades, BCR Signaling